(Q44750600)

English

Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Christina Vandenbroucke-Grauls

6

object named as

Vandenbroucke-Grauls CM

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Timmers GJ

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dijstelbloem Y

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Simoons-Smit AM

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

van Winkelhoff AJ

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Touw DJ

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Huijgens PC

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

847-853

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704431

0 references

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

21 January 2018

Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: a multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704431

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704431

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44750600&oldid=2162854937"